drugset / Trial / NCT05829317
Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients
Phase 4
Recruiting
200 enrolled
Dr. Stephanie Sibley
Canadian Institutes of Health Research (CIHR) · collabSoutheastern Ontario Academic Medical Organization (SEAMO) · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
A double-blind, multi-centre, randomized, placebo-controlled, feasibility pilot trial in the prevention of new onset atrial fibrillation of critically ill patients admitted to an ICU.
Timeline
- Start
- 2023-08-20
- Primary completion
- 2028-03-01
- Completion
- 2028-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 4 g | Intravenous |